SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001479290-19-000111
Filing Date
2019-12-10
Accepted
2019-12-10 20:38:45
Documents
2
Period of Report
2019-12-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_157602830859108.html 3  
1 FORM 3 wf-form3_157602830859108.xml 3 8549
2 SJUTS POA ex-24.htm EX-24 3640
  Complete submission text file 0001479290-19-000111.txt   13491
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Issuer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7555 GATEWAY BLVD NEWARK CA 94560
Business Address
Sjuts Dustin S (Reporting) CIK: 0001796224 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36297 | Film No.: 191278807